『海外』Weekly ニュース (2023/12/18 ～ )

(登録 2024/02/19)

📢 Oncoshot (https://www.oncoshot.com/)
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered Drug Development in China
https://www.prnewswire.com/apac/news-releases/oncoshot-teams-up-with-zhejiang-ablaze-medicine-to-drive-data-powered-drug-development-in-china-302021536.html

(登録 2024/02/19)

📢 Pearl (https://www.hellopearl.com/)
Pearl Granted U.S. Patent for Dental Practice Data Analysis AI Technology
https://www.businesswire.com/news/home/20231221135284/en

📢 Novarad Corporation (https://www.novarad.net/)
World's first pediatric deformity case using immersive augmented reality surgical navigation
https://www.prnewswire.com/news-releases/worlds-first-pediatric-deformity-case-using-immersive-augmented-reality-surgical-navigation-302021101.html

📢 
Europe's Cardiac AI Monitoring and Diagnostics Sector Reveals a Projected Surge in Market Value to $3.19 Billion by 2032, Driven by Technological Innovations and Growing AI Adoption in Cardiology
https://www.prnewswire.com/news-releases/europes-cardiac-ai-monitoring-and-diagnostics-sector-reveals-a-projected-surge-in-market-value-to-3-19-billion-by-2032--driven-by-technological-innovations-and-growing-ai-adoption-in-cardiology-302020916.html

(登録 2024/02/19)

📢 Samsung Electronics
Samsung Announces New Medications Tracking Feature for Samsung Health
https://news.samsung.com/global/samsung-announces-new-medications-tracking-feature-for-samsung-health

(登録 2024/02/19)

📢 ImpriMed (https://www.imprimedicine.com/)
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
Series A round led by SBVA (SoftBank Ventures Asia) to help expand ImpriMed’s services beyond veterinary medicine into human oncology
https://www.businesswire.com/news/home/20231219536657/en

📢 Dr. Ansay Ltd. (https://dransay.com/)
Global Market Leader for Online Doctor’s Notes for Paid Sick Leave Launches AtestadoMedico24.com in Brazil
Employees can declare their illness through an online questionnaire and receive a PDF from an online doctor within 5 minutes
https://www.businesswire.com/news/home/20231219560164/en/Global-Market-Leader-for-Online-Doctor%E2%80%99s-Notes-for-Paid-Sick-Leave-Launches-AtestadoMedico24.com-in-Brazil

📢 Owkin (https://www.owkin.com/)
Owkin conclut un accord de collaboration avec MSD pour développer des diagnostics basés sur l’IA pour le cancer
* Owkin va collaborer avec MSD pour développer et commercialiser des diagnostics de pathologie numérique MSI-H (Microsatellite Instability High) basés sur l’IA pour quatre types de cancer.
https://www.businesswire.com/news/home/20231219889680/en/Owkin-enters-collaboration-agreement-with-MSD-to-develop-AI-powered-diagnostics-for-cancer

📢 Outcomes4Me (https://www.outcomes4me.com/)
New study finds the majority of cancer patients use online resources at least several times a week to manage their care
https://www.prnewswire.com/news-releases/new-study-finds-the-majority-of-cancer-patients-use-online-resources-at-least-several-times-a-week-to-manage-their-care-302019351.html

📢 ShiraTronics (https://shiratronics.com/)
ShiraTronics Announces Landmark Achievement: World's First Implant of its Innovative Chronic Migraine System
https://www.prnewswire.com/news-releases/shiratronics-announces-landmark-achievement-worlds-first-implant-of-its-innovative-chronic-migraine-system-302018076.html

(登録 2023/12/19)

📢 Ruten Inc (https://www.ruten-neuro.com/)
侵襲型Brain-Machine Interfaceに取り組む医療機器ベンチャーRuten Incがプレシードラウンドにて資金調達を実施
身体機能の再建を目的とする侵襲型Brain-Machine Interfaceの開発を加速
https://prtimes.jp/main/html/rd/p/000000001.000134786.html

📢 Biorithm (https://www.bio-rithm.com/)
Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide
https://prnmedia.prnewswire.com/news-releases/biorithm-secures-3-5-million-in-series-a-funding-to-advance-maternal-care-worldwide-302017626.html
[参考：AI抄訳]
女性の健康を専門とするメディカルテクノロジー企業Biorithmが、シリーズAの資金調達で350万ドルを獲得しました。この資金は、東南アジアとアメリカ市場での事業拡大、および、妊娠中の母親向け遠隔モニタリングソリューション「Femom」の研究進展に充てられます。Femomは、クリニシャンが合併症の兆候を早期に発見するのを助ける技術です。また、米国食品医薬品局に510(K)プレマーケット申請を行うための臨床試験完了も支援します。

📢 Masimo (https://www.masimostork.com/en-us/)
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
Stork Provides Continuous Monitoring of Oxygen Saturation, Pulse Rate, and Skin Temperature, with Alarms, for Sick and Healthy Babies at Home
https://www.businesswire.com/news/home/20231218419637/en
[参考：AI抄訳]
Masimo社が、0〜18ヶ月の健康及び病気の赤ちゃん向けにStork™ベビーモニタリングシステムのFDA認証を取得しました。Storkは、酸素飽和度、脈拍数、皮膚温度を連続監視し、異常がある際にはアラームで知らせます。家庭で処方として使用可能で、保護者は重要なバイタルデータを遠隔で医療従事者と共有できるようになります。また、赤ちゃんがうつぶせで寝ている場合に警告を発します。

[参考：AI抄訳] では、リンク先の要旨を短時間で斜め読みいただく目的で、
OpenAI社の生成AI「ChatGPT」を利用した抄訳 (翻訳･要約) を付記しております。
内容の正確性 などを保証するものではありませんこと、ご留意ください。

以上